Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H32O2 |
| Molecular Weight | 292.4562 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O
InChI
InChIKey=CBMYJHIOYJEBSB-YSZCXEEOSA-N
InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17-,18-,19-/m0/s1
| Molecular Formula | C19H32O2 |
| Molecular Weight | 292.4562 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| ERbeta: recent understanding of estrogen signaling. | 2010-09 |
|
| Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol. | 2010-09 |
|
| The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta. | 2010-09 |
|
| Effects of CYP7B1-mediated catalysis on estrogen receptor activation. | 2010-09 |
|
| Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. | 2010-08 |
|
| ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. | 2010-04-13 |
|
| Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone. | 2009-12-10 |
|
| Assessment of metabolic capabilities of PLHC-1 and RTL-W1 fish liver cell lines. | 2009-12 |
|
| MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. | 2009-09-29 |
|
| Androgens upregulate cyp19a1b (aromatase B) gene expression in the brain of zebrafish (Danio rerio) through estrogen receptors. | 2009-05 |
|
| The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. | 2009-05 |
|
| Detection of anabolic steroids in dietary supplements: the added value of an androgen yeast bioassay in parallel with a liquid chromatography-tandem mass spectrometry screening method. | 2009-04-01 |
|
| Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer. | 2009-03-25 |
|
| A role for the androgen metabolite, 5alpha-androstane-3beta,17beta-diol, in modulating oestrogen receptor beta-mediated regulation of hormonal stress reactivity. | 2009-03 |
|
| Epimerase activity of the human 11beta-hydroxysteroid dehydrogenase type 1 on 7-hydroxylated C19-steroids. | 2009-03 |
|
| Steroid hormone transforming aldo-keto reductases and cancer. | 2009-02 |
|
| Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. | 2008-11 |
|
| An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. | 2008-05 |
|
| CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling. | 2008-04 |
|
| Estrogen sensitivity of target genes and expression of nuclear receptor co-regulators in rat prostate after pre- and postnatal exposure to the ultraviolet filter 4-methylbenzylidene camphor. | 2007-12 |
|
| 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. | 2007-12 |
|
| 5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1. | 2007-11 |
|
| Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. | 2007-09-15 |
|
| Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells. | 2007-07 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Effects of 3-beta-diol, an androgen metabolite with intrinsic estrogen-like effects, in modulating the aquaporin-9 expression in the rat efferent ductules. | 2006-10-06 |
|
| Triphenyltin alters androgen metabolism in the sea urchin Paracentrotus lividus. | 2006-09-12 |
|
| Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells. | 2006-06-02 |
|
| 17beta-estradiol induces apoptosis in the developing rodent prostate independently of ERalpha or ERbeta. | 2006-01 |
|
| Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. | 2006-01 |
|
| The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. | 2005-06-15 |
|
| Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. | 2004-12-01 |
|
| The human cytochrome P4507B1: catalytic activity studies. | 2004-12 |
|
| Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. | 2004-12 |
|
| HPLC-RIA analysis of steroid hormone profile in a virilizing stromal tumor of the ovary. | 2004-10-29 |
|
| Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. | 2004-07 |
|
| Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. | 2004-03-12 |
|
| Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. | 2004 |
|
| Proposed mechanism for sperm chromatin condensation/decondensation in the male rat. | 2003-02-11 |
|
| Photoaffinity labeling of human sex hormone-binding globulin using 17alpha-alkylamine derivatives of 3beta-androstanediol substituted with azidonitrophenylamido, azidonitrophenylamino, or trifluoroazidonitrophenylamino chromophores. Localization of Trp-84 in the vicinity of the steroid-binding site. | 2001-12-18 |
|
| Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation. | 2001-06-29 |
|
| In-vitro metabolism of [3H]testosterone by scalp and back skin: conversion of testosterone into 5alpha-androstane-3beta, 17beta-diol. | 1977-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:25 GMT 2025
by
admin
on
Mon Mar 31 17:48:25 GMT 2025
|
| Record UNII |
6J0K4253QD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
9640-4
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
LOINC |
15026-8
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
LOINC |
1850-7
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
||
|
LOINC |
23815-4
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
50891
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
DTXSID8022379
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
DB03882
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
6J0K4253QD
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
209-334-3
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
3?-Androstanediol
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
18329
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
571-20-0
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
242332
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY | |||
|
27727
Created by
admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE | |||
|
PARENT -> METABOLITE |
IN VITRO
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |